Fusoh Pharmaceutical Industries (4538) Reports Earnings: Operating Profit Up 63.0% YoY to 972 Million Yen

Fusoh Pharmaceutical Industries (4538) has released its financial results, reporting net sales of 16,046 million yen, representing a 3.5% increase compared to the same period of the previous year. Profitability showed significant improvement, with operating profit surging 63.0% YoY to 972 million yen, ordinary profit rising 40.9% YoY to 911 million yen, and net profit increasing 39.0% YoY to 642 million yen.

Regarding the financial position and cash flows, the equity ratio stands at 40.9% with cash and cash equivalents of 4,850 million yen. Interest-bearing debt is recorded at 26,310 million yen and retained earnings as of June 30, 2026 stand at 14,139 million yen. Operating cash flow was -6,220 million yen and free cash flow was -7,740 million yen. While cash outflows related to investments and working capital are observed, investors will continue to monitor the company's capital allocation and ongoing financial management.

---

Correction (September 19, 2026)：The affected figures and reporting-period labels were corrected after checking the source disclosure. Source disclosure